Diversity by Divergence: Solution-Phase Parallel Synthesis of a Library of N-Diversified 1-Oxa-7-Azaspiro[4.5]decan-2-yl-Propanes and -Butanes

ACS Combinatorial Science

Volumn 15, Issue 11, 2013, Pages 564-571

  Kumar, Sarvesh ^a   Thornton, Paul D ^a   Santini, Conrad ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

branching pathways; divergent synthesis; multistage diversification; saturated library compound synthesis; saturated scaffolds; stereogenic spirocycles

Indexed keywords

FURAN DERIVATIVE; MOLECULAR LIBRARY; PIPERIDINE DERIVATIVE; SOLUTION AND SOLUBILITY; SPIRO COMPOUND;

CHEMICAL STRUCTURE; CHEMISTRY; MOLECULAR LIBRARY; SOLUTION AND SOLUBILITY; STEREOISOMERISM; SYNTHESIS;

FURANS; MOLECULAR STRUCTURE; PIPERIDINES; SMALL MOLECULE LIBRARIES; SOLUTIONS; SPIRO COMPOUNDS; STEREOISOMERISM;

EID: 84887584001     PISSN: 21568952     EISSN: None     Source Type: Journal    
DOI: 10.1021/co4001056     Document Type: Article

References (14)

1. Lovering, F.; Bikker, J.; Humblet, C. Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success J. Med. Chem. 2009, 52 (21) 6752-6756
2. Burke, M. D.; Schreiber, S. L. A Planning Strategy for Diversity-Oriented Synthesis Angew. Chem., Int. Ed. 2004, 43, 46-58
3. Gerard, B.; Lee, M. D., IV; Dandapani, S.; Duvall, J. R.; Fitzgerald, M. E.; Kesavan, S.; Lowe, J. T.; Marié, J.-C.; Pandya, B. A.; Suh, B.-C.; O'Shea, M. W.; Dombrowski, M.; Hamann, D.; Lemercier, B.; Murillo, T.; Akella, L. B.; Foley, M. A.; Marcaurelle, L. A. Synthesis of Stereochemically and Skeletally Diverse Fused Ring Systems from Functionalized C-Glycosides J. Org. Chem. 2013, 78, 5160-5171
4. LaPorte, M. G.; Tsegay, S.; Hong, K. B.; Lu, C.; Fang, C.; Wang, L.; Xie, X.-Q.; Floreancig, P. E. Construction of a Spirooxindole Amide Library through Nitrile Hydrozirconation-Acylation-Cyclization Cascade ACS Comb. Sci. 2013, 15, 344-349
5. Beierle, J. M.; Horne, W. S.; van Maarseveen, J. H.; Waser, B.; Reubi, J. C.; Ghadiri, M. R. Conformationally Homogeneous Heterocyclic Pseudotetrapeptides as Three-Dimensional Scaffolds for Rational Drug Design: Receptor-Selective Somatostatin Analogues Angew. Chem., Int. Ed. 2009, 48, 4725-4729
6. Lloyd, R. C.; Smith, M. E. B.; Brick, D.; Taylor, S. J. C.; Chaplin, D. A.; McCague, R. Chemoenzymatic Synthesis of the Four Diastereoisomers of 4-Hydroxypipecolic Acid from N-Acetyl-(R,S)-allylglycine: Chiral Scaffolds for Drug Discovery Org. Process Res. Dev. 2002, 6, 762-766
7. Cheng, M.-N.; Wang, H.; Gong, L.-J. Asymmetic Organocatalytic 1,3-Dipolar Cycloaddition of Azomethine Ylide to Methyl 2-(2-Nitrophenyl)acrylate for the Synthesis of Diastereoisomers of Spirotryprostatin A Org. Lett. 2011, 13, 2418-2421
8. Kyranos, J. N.; Lee, H.; Goetzinger, W. K.; Li, L. Y. T. One-Minute Full-Gradient HPLC/UV/ELSD/MS Analysis to Support High-Throughput Parallel Synthesis J. Comb. Chem. 2004, 6, 796-804
9. Kumar, S.; Thornton, P. D.; Painter, T.; Jain, P.; Downard, J.; Douglas, J. T.; Santini, C. Synthesis of a Family of Spirocyclic Scaffolds: Building Blocks for the Exploration of Chemical Space J. Org. Chem. 2013, 78, 6529-6539
10. Baldwin, J. E. Rules for Ring Closure J. Chem. Soc., Chem. Commun. 1976, 734-736
11. Mancuso, A. J.; Brownfain, D. S.; Swern, D. Structure of the Dimethyl Sulfoxide-Oxalyl Chloride Reaction Product. Oxidations of Heteroaromatic and Diverse Alcohols to Carbonyl Compounds J. Org. Chem. 1979, 44, 4148-4150
12. Langer, P. Tetra-n-propyl Ammonium Perruthenate (TPAP)-An Efficient and Selective Reagent for Oxidation Reactions in Solution and on the Solid Phase J. Prakt. Chem. 2000, 342, 728-730
13. Yao, W.; He, C.; Zhuo, J.; Xu, M.; Zhang, C.; Qian, D.-Q.; Burns, D.; Metcalf, B. W. Preparation of Lactams, Particularly 2,7-Diazaspiro[4.5]decan-1-one Derivatives, as 11-β Hydroxysteroid Dehydrogenase Type 1 Inhibitors and Mineralocorticoid Receptor Antagonists and Their Use As Pharmaceuticals. PCT Int. Appl. 2006053024, 18 May 2006.
14. Yao, W.; He, C.; Burns, D. M.; Zhuo, J.; Xu, M.; Zhang, C.; Qian, D.-Q.; Metcalf, B. Lactam Compounds As 11β-HDS1 Inhibitors and MR Antagonists and Their Preparation and Use in the Treatment of Diseases. U.S. Pat. Appl. Publ. 20090291946, 26 Nov 2009.